Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.

Portfolio

Loading...
Select Portfolio and Asset Combination for Display on Market Band
Select Portfolio
Select Asset Class
Show More
Download ET MARKETS APP

Get ET Markets in your own language

DOWNLOAD THE APP NOW

+91

CHOOSE LANGUAGE

ENG

  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা
  • KAN - ಕನ್ನಡ
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
Drag according to your convenience
ET NOW RADIO
ET NOW
TIMES NOW

US drugstore chain CVS to acquire insurer Aetna for $69 billion

Reuters|
Updated: Dec 05, 2017, 12.05 AM IST
0Comments
Aetna shareholders stand to receive $207 per share in the deal with CVS.
Aetna shareholders stand to receive $207 per share in the deal with CVS.

NEW YORK: US drugstore chain operator CVS Health Corp said on Sunday it had agreed to acquire US health insurer Aetna Inc for $69 billion, seeking to tackle soaring healthcare spending through lower-cost medical services in pharmacies. This year’s largest corporate acquisition will combine one of the nation’s largest pharmacy benefits managers (PBMs) and pharmacy operators with one of its oldest health insurers, whose national business ranges from employer healthcare to government plans.

The deal comes after Aetna’s $37-billion plan to acquire smaller US health insurance peer Humana Inc was blocked in January by a US federal judge over antitrust concerns. A proposed combination of peers Anthem Inc and Cigna Corp was also shot down. Aetna shareholders stand to receive $207 per share in the deal with CVS, the companies said. The consideration comprises $145 per share in cash and 0.8378 CVS shares for each Aetna share.

Reuters first reported the terms of the deal earlier on Sunday. Aetna shareholders will own about 22% of the combined company, while CVS shareholders will own the remainder.

The companies said that cost synergies in the second full year after the transaction closes — 2020 if the deal closes in the second half of 2018 as they expect — would amount to $750 million. They foresee it adding to adjusted earnings per share by the lowto mid-single digit percentage points.

Their vision expands beyond capitalising on CVS’ existing MinuteClinic structure, which largely offers preventative services like flu shots, the companies’ chief executives said in an interview.

“When you walk into CVS there’s the pharmacy. What if there’s a vision and audiology center, and perhaps a nutritionist, and some sort of care manager?” CVS CEO Larry Merlo said. Aetna will be operated as a separate unit and Aetna’s existing leadership is expected to run the Aetna businesses, Merlo said. Aetna will have two of its directors, in addition to Aetna CEO Mark Bertolini join the board of CVS.
0Comments

Also Read

CVS bid for Aetna: A $66 billion bet on cutting drug costs

Demonetisation at work: Two wheelers, CVs worst hit in November

CVs should bounce back the fastest: Gautam Trivedi, Religare Capital

See greater demand for microfinance, CVs via rural push: HKN Raghavan, Equitas Holdings

Rivigo places single largest order for 1200 CVs from Ashok Leyland

Comments
Add Your Comments

Loading
Please wait...